Synthesis and In Vitro Antiproliferative Activity of 11-Substituted Neocryptolepines with a Branched ω-Aminoalkylamino Chain

Neocryptolepine, which is a kind of tetracyclic indoloquinoline alkaloid, exhibits the inhibition of topoisomerase II and shows antiproliferative activity. The present study describes the synthesis and antiproliferative evaluation of several neocryptolepine analogues carrying a branched, functionali...

Full description

Saved in:
Bibliographic Details
Published inMolecules (Basel, Switzerland) Vol. 22; no. 11; p. 1954
Main Authors Shaban, Elkhabiry, Świtalska, Marta, Wang, Li, Wang, Ning, Xiu, Fan, Hayashi, Ikuya, Ngoc, Tran Anh, Nagae, Sachie, El-Ghlban, Samah, Shimoda, Shiho, Gokha, Ahmed Abdel Aleem El, Sayed, Ibrahim El Tantawy El, Wietrzyk, Joanna, Inokuchi, Tsutomu
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 12.11.2017
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Neocryptolepine, which is a kind of tetracyclic indoloquinoline alkaloid, exhibits the inhibition of topoisomerase II and shows antiproliferative activity. The present study describes the synthesis and antiproliferative evaluation of several neocryptolepine analogues carrying a branched, functionalized dibasic side chain at C11. These 2-substituted 5-methyl-indolo[2,3-b]quinoline derivatives were prepared by nucleophilic aromatic substitution (S Ar) of 11-chloroneocryptolepines with appropriate 1,2- and 1,3-diamines. Some of the 11-(ω-aminoalkylamino) derivatives were further transformed into 11-ureido and thioureido analogues. Many of the prepared neocryptolepine derivatives showed submicromolar antiproliferative activity against the human leukemia MV4-11 cell line. Among them, 11-(3-amino-2-hydroxy)propylamino derivatives and 2k were the most cytotoxic with a mean IC value of 0.042 μM and 0.057 μM against the MV4-11 cell line, 0.197 μM and 0.1988 μM against the A549 cell line, and 0.138 μM and 0.117 μM against the BALB/3T3 cell line, respectively.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1420-3049
1420-3049
DOI:10.3390/molecules22111954